Latest articles

2020 Annual Report

Pharmaceutical Utilisation January, 2020 – December, 2020

September 2021

National report: Overview of national dispensing during 2020

September 2021

Follow-up and surveillance for people after treatment for bowel cancer

Bowel cancer is a leading cause of cancer mortality in New Zealand,...

August 2021

Surveillance for people with polyps or inflammatory bowel disease

Guidance for following up people who have had polyps identified...

August 2021

Childhood eczema: improving adherence to treatment basics

Emollients form the basis of treatment for all patients with...

August 2021

Topical corticosteroids for childhood eczema: clearing up the confusion

Topical corticosteroids are one of the key medicines used in...

August 2021

Managing gout in primary care
Part 1 - Talking about gout: time for a re-think

Gout is a treatable form of arthritis that is associated with...

July 2021

Managing gout in primary care
Part 2 -  Controlling gout with long-term urate-lowering treatment

Urate-lowering medicines should be considered and discussed...

July 2021

Contraception: which option for which patient?

Prescribing contraception is a core part of primary care practice....

July 2021

Condoms: advising on the options

Condoms are the only form of contraception that protects against...

July 2021

Oral contraceptives: selecting a pill

Oral contraceptive pills are a safe and effective contraceptive...

July 2021

Depot medroxyprogesterone acetate (DMPA) injections: an intermediate option

Depot medroxyprogesterone acetate injections are a form of hormonal...

July 2021

Long-acting contraceptives: implants and IUCs

Long-acting reversible contraceptives include progestogen (levonorgestrel)...

July 2021

Peer group discussion: What’s new in contraception?

The following questions can be used as discussion points for...

July 2021

Prescribing vildagliptin for type 2 diabetes

With two new medicines, empagliflozin and dulaglutide, available...

July 2021

New diabetes medicines funded: empagliflozin and dulaglutide

Sodium-glucose co-transporter 2 (SGLT-2) inhibitors and glucagon-like...

July 2021

Initiating insulin for people with type 2 diabetes

Due to its progressive nature, many people with type 2 diabetes...

July 2021

Clinician’s Notepad: type 2 diabetes

July 2021

A rising tide of type 2 diabetes in younger people: what can primary care do?

An increasing incidence of early onset type 2 diabetes in New...

July 2021

Type 2 diabetes management toolbox: from lifestyle to insulin

The management of type 2 diabetes is multi-faceted, including...

July 2021

Weight loss for the prevention and treatment of type 2 diabetes

Obesity is contributing to the increasing rate of type 2 diabetes...

July 2021

The annual diabetes review: screening, monitoring and managing complications

An annual diabetes review allows for assessment of glycaemic...

July 2021

Lead absorption notification levels have reduced

On 9 April, 2021, the level at which lead absorption becomes...

June 2021

Baseline testing before treatment with ACE inhibitors/ARBs

This audit focuses on the measurement of serum creatinine (to...

May 2021

The role of medicines in the management of depression in primary care

A selective serotonin reuptake inhibitor (SSRI) is usually the...

May 2021

Management of impetigo

Impetigo is a highly contagious, bacterial infection of the...

May 2021

Prescribing statins to reduce cardiovascular risk

Lowering lipid levels should be viewed as one aspect of reducing...

May 2021

Cancer care: the role of primary care in identifying and managing cachexia

Through improvements in diagnosis and treatment, one in three...

April 2021

Prescribing ACE inhibitors: time to reconsider old habits

Prescribers in New Zealand are highly reliant on cilazapril...

March 2021

Peer group discussion: Early detection of lung cancer in primary care

The following questions can be used as discussion points for...

March 2021

Clinical Audit: Reviewing type 2 diabetes management in patients at high risk of cardiovascular and renal complications

This audit helps health professionals in primary care identify...

March 2021

Early detection of lung cancer in primary care

Lung cancer is one of the most common cancers in New Zealand...

March 2021

An update on the pharmacological management of stable COPD

New national guidelines for the management of chronic obstructive...

February 2021

The COPD tool for modifying pharmacological treatment - Tool 1

The patient has been diagnosed with COPD but has not been prescribed...

February 2021

The COPD tool for modifying pharmacological treatment - Tool 2

The patient is currently taking long-term inhaled medicines...

February 2021

Benzodiazepines and zopiclone: is overuse still an issue?

Despite being recommended for short-term use only, and usually...

February 2021

Endometriosis: diagnosis and management

Endometriosis is characterised by the presence of endometrial-like...

February 2021

Limiting the use of quinolone antibiotics

Quinolones (e.g. ciprofloxacin, norfloxacin) are associated...

February 2021

Inflammatory bowel disease – a focus on Crohn’s disease and ulcerative colitis

Crohn’s disease and ulcerative colitis are the principal forms...

February 2021

Withdrawing patients from long-term use of benzodiazepines or zopiclone

Stopping benzodiazepine or zopiclone treatment in people who...

February 2021

Peer group discussion: Limiting the use of quinolone antibiotics

The following questions can be used as discussion points for...

December 2020

Appropriate use of zopiclone and benzodiazepines for the treatment of insomnia

Zopiclone and some benzodiazepines, such as temazepam and triazolam,...

December 2020

Consider blue-green algal blooms this summer: Identifying and managing suspected cyanotoxin poisoning in primary care

Cyanobacteria, also referred to as blue-green algae, are micro-organisms...

November 2020

Made with by the bpacnz team

Partner links